PUMA BIOTECHNOLOGY, INC. Income Taxes Paid
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Income Taxes Paid of $624.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2026-08-06
- PUMA BIOTECHNOLOGY, INC. income taxes paid for the quarter ending 2026-06-30 was $615.00K, a 33.80% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. income taxes paid for the quarter ending 2026-03-31 was $9.00K, a 91.09% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. income taxes paid for the quarter ending 2025-12-31 was $247.00K, a 414.58% increase year-over-year.
- PUMA BIOTECHNOLOGY, INC. income taxes paid for the quarter ending 2025-09-30 was $247.00K, a 0.40% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. income taxes paid for fiscal 2025 was $1.52M, a 25.12% increase from fiscal 2024.
- PUMA BIOTECHNOLOGY, INC. income taxes paid for fiscal 2024 was $1.22M, a 65.26% increase from fiscal 2023.
- PUMA BIOTECHNOLOGY, INC. income taxes paid for fiscal 2023 was $737.00K, a 91.93% increase from fiscal 2022.
- PUMA BIOTECHNOLOGY, INC. income taxes paid for fiscal 2022 was $384.00K, a 18.52% increase from fiscal 2021.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | $615.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $624.00K 10-Q · filed 2026-08-06 | $871.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.12M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $9.00K 10-Q · filed 2026-05-07 | $256.00K derived: sum of 2 quarters · filed 2026-05-07 | $503.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.43M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $247.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $494.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.42M derived: sum of 3 quarters · filed 2026-08-06 | $1.52M 10-K · filed 2026-02-26 |
| 2025-09-30 | $247.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.18M derived: sum of 2 quarters · filed 2026-08-06 | $1.28M 10-Q · filed 2025-11-06 | $1.32M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $929.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.03M 10-Q · filed 2026-08-06 | $1.08M derived: sum of 3 quarters · filed 2026-08-06 | $1.33M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $101.00K 10-Q · filed 2026-05-07 | $149.00K derived: sum of 2 quarters · filed 2026-05-07 | $397.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.20M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $296.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.10M derived: sum of 3 quarters · filed 2026-02-26 | $1.22M 10-K · filed 2026-02-26 |
| 2024-09-30 | $248.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.05M derived: sum of 2 quarters · filed 2025-11-06 | $1.17M 10-Q · filed 2025-11-06 | $1.42M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $922.00K 10-Q · filed 2025-08-07 | $1.17M derived: sum of 3 quarters · filed 2026-02-26 | $1.42M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $122.00K 10-Q · filed 2025-05-08 | $368.00K derived: sum of 2 quarters · filed 2026-02-26 | $621.00K derived: sum of 3 quarters · filed 2026-02-26 | $717.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $246.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $499.00K derived: sum of 2 quarters · filed 2026-02-26 | $595.00K derived: sum of 3 quarters · filed 2026-02-26 | $737.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $253.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $349.00K derived: sum of 2 quarters · filed 2024-11-07 | $491.00K 10-Q · filed 2024-11-07 | $734.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $96.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $238.00K 10-Q · filed 2024-08-01 | $481.00K derived: sum of 3 quarters · filed 2025-02-27 | $481.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $142.00K 10-Q · filed 2024-05-02 | $385.00K derived: sum of 2 quarters · filed 2025-02-27 | $385.00K derived: sum of 3 quarters · filed 2025-02-27 | $526.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $243.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $243.00K derived: sum of 2 quarters · filed 2025-02-27 | $384.00K derived: sum of 3 quarters · filed 2025-02-27 | $384.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $141.00K derived: sum of 2 quarters · filed 2023-11-02 | $141.00K 10-Q · filed 2023-11-02 | $381.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $141.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $141.00K 10-Q · filed 2023-08-03 | $381.00K derived: sum of 3 quarters · filed 2024-02-29 | $381.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 | $240.00K derived: sum of 2 quarters · filed 2024-02-29 | $240.00K derived: sum of 3 quarters · filed 2024-02-29 | $312.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $240.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $240.00K derived: sum of 2 quarters · filed 2024-02-29 | $312.00K derived: sum of 3 quarters · filed 2024-02-29 | $324.00K 10-K · filed 2024-02-29 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $72.00K derived: sum of 2 quarters · filed 2022-11-03 | $84.00K 10-Q · filed 2022-11-03 | $108.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | $72.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $84.00K 10-Q · filed 2022-08-04 | $108.00K derived: sum of 3 quarters · filed 2023-03-02 | |
| 2021-03-31 | $12.00K 10-Q · filed 2022-05-05 | $36.00K derived: sum of 2 quarters · filed 2023-03-02 | ||
| 2020-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $207.00K 10-K · filed 2023-03-02 | ||
| 2020-09-30 | $183.00K 10-Q · filed 2021-11-04 | |||
| 2019-12-31 | $53.00K 10-K · filed 2022-03-03 | |||
| 2018-12-31 | $17.00K 10-K · filed 2021-03-01 | |||
| 2011-06-30 | $0.00 10-Q · filed 2011-08-15 | |||
| 2010-06-30 | $0.00 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |